MSI Financial Services Inc - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
MSI Financial Services Inc ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2016$10,000
-65.5%
4,800
-44.7%
0.00%
-100.0%
Q3 2016$29,000
+7.4%
8,682
+0.0%
0.00%0.0%
Q2 2016$27,000
-6.9%
8,678
+1.2%
0.00%0.0%
Q1 2016$29,000
+45.0%
8,578
+53.8%
0.00%0.0%
Q4 2015$20,0000.0%5,578
+80.8%
0.00%0.0%
Q2 2015$20,000
-20.0%
3,085
-14.4%
0.00%
-50.0%
Q1 2015$25,000
-30.6%
3,606
-23.3%
0.00%
-50.0%
Q4 2014$36,0004,7000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
Westside Investment Management, Inc. 500$00.00%
Ancora Advisors LLC 4,948$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
View complete list of PDL BIOPHARMA INC shareholders